<DOC>
	<DOC>NCT01123772</DOC>
	<brief_summary>The purpose of this study is to evaluate how tolerable and safe it is to give INO-8875 eye drops at different concentrations to normal older healthy adult volunteers for two weeks.</brief_summary>
	<brief_title>Phase I Dose-Escalation Study to Evaluate Tolerability, Safety &amp; PK of INO-8875 in Healthy Older-Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Adenosine</mesh_term>
	<criteria>male, or a female with a negative pregnancy test and without childbearing potential aged 35 to 65 years body weight is ≥50 kg and ≤115 kg Subject has glaucoma or any active ophthalmologic disease including conjunctivitis Subject has a central retinal vein occlusion in either eye at any time in the past Subject is currently on any drug that might affect IOP including oral or ocular glucocorticoids or ephedrine Subject has history of ocular trauma or surgery (except for nonincisional surgery performed at least 3 months prior to the Screening visit) Subject has a prosthetic eye or any ocular abnormality precluding reliable applanation tonometry in either eye including an immobile pupil. Subject is not able to refrain from use of contact lenses during the Treatment Period</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>adenosine agonist</keyword>
	<keyword>eye drop</keyword>
	<keyword>elderly volunteer</keyword>
	<keyword>older healthy volunteer</keyword>
</DOC>